Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University: Carcinoma trials

The registry lists 14 Carcinoma studies with Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 10Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCCRecruitingNCT06876844Phase 2
• Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)Not yet recruitingNCT06647563Phase 3
• Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell CarcinomaRecruitingNCT06470217Phase 2
• Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell CarcinomaNot yet recruitingNCT05806073Not applicable
• Surgical Strategy for Head and Neck Adenoid Cystic CancerCompletedNCT06778915
• Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma PatientsStatus unknownNCT05611463Phase 2
• Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland CarcinomasStatus unknownNCT05013515Not applicable
• Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell CarcinomaStatus unknownNCT04440917Phase 2
• All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT04433169Phase 2
• A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT03267121Phase 2
• A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck CancersStatus unknownNCT03096184Phase 2
• Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and NeckCompletedNCT02776137Phase 2
• Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma PatientsCompletedNCT02776124Phase 2
• A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT02775370Phase 2